Ying-Chun Lo
Clinical Pathology/Laboratory Medicine · Rochester, MNNPI 1487032470
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,168 of the $17,253 with a category attached, or 87.9%. Boehringer Ingelheim accounts for 69.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $11,285, 6.7 times the $1,680 reported in 2021.
Across 22 payments — averaging $784.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$12K
- Sanofi$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Chromacode, Inc$2K
- Merck$18
Across 1 payment — averaging $15,190 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biocartis US, Inc$15K
What the payments were for
- Consulting fees$15,16888%
- Travel & lodging$1,4148%
- Food & beverage$6534%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 17 | $12,038 |
| Sanofi | 2 | $2,017 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,680 |
| Chromacode, Inc | 1 | $1,500 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXKIVITY$1,680
How this compares
$17,253 in reported general payments places this provider in the 85th percentile of 30 clinical pathology/laboratory medicine providers in Minnesota.
See all clinical pathology/laboratory medicine providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in Rochester
- Henry HomburgerRochester$221K
- Rondell GrahamRochester$71K
- Kristina MatkowskyjRochester$65K
- Neil AndersonRochester$41K
- Brad KaronRochester$6K
- Patricia GreippRochester$4K
- Monica KleinRochester$1K
- James CaseyRochester$262
- Anand PadmanabhanRochester$250
- Sarah ThomasRochester$182
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.